SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001445305-14-001073
Filing Date
2014-03-17
Accepted
2014-03-17 16:25:50
Documents
15
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mrtx-20131231x10k.htm 10-K 1484528
2 EXHIBIT mrtx-20131231xex231.htm EX-23.1 4455
3 EXHIBIT mrtx-20131231xex311.htm EX-31.1 11189
4 EXHIBIT mrtx-20131231xex312.htm EX-31.2 11923
5 EXHIBIT mrtx-20131231xex321.htm EX-32.1 7890
12 graph1.jpg GRAPHIC 40533
13 graph2.jpg GRAPHIC 35301
14 graph4.jpg GRAPHIC 34454
15 graph5.jpg GRAPHIC 45855
  Complete submission text file 0001445305-14-001073.txt   8457676

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mrtx-20131231.xml EX-101.INS 1245442
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrtx-20131231.xsd EX-101.SCH 51364
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrtx-20131231_cal.xml EX-101.CAL 74339
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrtx-20131231_def.xml EX-101.DEF 173395
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrtx-20131231_lab.xml EX-101.LAB 668873
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrtx-20131231_pre.xml EX-101.PRE 348857
Mailing Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 (514) 337-3333
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35921 | Film No.: 14697881
SIC: 2834 Pharmaceutical Preparations